z-logo
open-access-imgOpen Access
Androgen deprivation causes selective deficits in the biomechanical leg muscle function of men during walking: a prospective case–control study
Author(s) -
Cheung Ada S.,
Gray Hans,
Schache Anthony G.,
Hoermann Rudolf,
Lim Joon Daryl,
Zajac Jeffrey D.,
Pandy Marcus G.,
Grossmann Mathis
Publication year - 2017
Publication title -
journal of cachexia, sarcopenia and muscle
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.803
H-Index - 66
eISSN - 2190-6009
pISSN - 2190-5991
DOI - 10.1002/jcsm.12133
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , iliopsoas muscle , ankle , testosterone (patch) , prospective cohort study , biomechanics , physical medicine and rehabilitation , statistical significance , preferred walking speed , stride , urology , gait , physical therapy , surgery , cancer , anatomy , abscess
Background Although muscle mass declines with testosterone deficiency in men, previous studies of muscle function have not demonstrated consistent deficits, likely due to relatively insensitive methodology. Our objective was to determine the effects of testosterone deprivation on the biomechanical function of individual lower‐limb muscles. Methods We conducted a 12‐month prospective, observational case–control study of 34 men newly commencing androgen deprivation treatment (ADT) for prostate cancer and 29 age‐matched prostate cancer controls. Participants were assessed at 0, 6, and 12 months while walking in a biomechanics laboratory. We combined video‐based motion capture and ground reaction force data with computerized musculoskeletal modelling to assess the following primary outcomes: (i) peak joint torques at the hip, knee and ankle, and corresponding individual muscle forces; (ii) individual muscle contributions to acceleration of the body's centre of mass; and (iii) walking speed, stride length, and step width. A linear mixed model was used to compare mean differences between groups. Results Compared with controls over 12 months, men receiving ADT had a mean reduction in total testosterone level from 14.1 to 0.4 nmol/L, and demonstrated more marked decreases in peak hip flexor torque by 14% [mean difference −0.11 N/kg (−0.19, −0.03), P  = 0.01] and peak knee extensor torque by 16% [−0.11 N/kg (−0.20, −0.02), P  = 0.02] of the initial mean value. Correspondingly, iliopsoas force decreased by 14% ( P  = 0.006), and quadriceps force decreased by 11%, although this narrowly missed statistical significance ( P  = 0.07). Soleus decreased contribution to forward acceleration of the body's centre of mass by 17% [mean difference −0.17 m/s 2 (−0.29, −0.05), P  < 0.01]. No significant changes between groups were observed in other joint torques or individual muscle contributions to acceleration of the body. Step width increased by 18% [mean adjusted difference 1.4 cm (0.6, 27.4), P  = 0.042] in the ADT group compared with controls, with no change in stride length or walking speed. Conclusions Testosterone deprivation selectively decreases lower‐limb muscle function, predominantly affecting muscles that support body weight, accelerate the body forwards during walking, and mediate balance. Future exercise and pro‐myogenic interventional studies to mitigate ADT‐associated sarcopenia should target these deficits.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here